Tifcemalimab Combined with Toripalimab and Chemotherapy As 1st Line Treatment for Extensive-Stage Small Cell Lung Cancer (ES-SCLC): A Phase Ib/II, Open-Label Study.
JOURNAL OF CLINICAL ONCOLOGY（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined